Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype.
Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van der Vijver M, Parry S, Bishop T, Benitez J, Rivas C, Bignon YJ, Chang-Claude J, Hamann U, Cornelisse CJ, Devilee P, Beckmann MW, Nestle-Krämling C, Daly PA, Haites N, Varley J, Lalloo F, Evans G, Maugard C, Meijers-Heijboer H, Klijn JG, Olah E, Gusterson BA, Pilotti S, Radice P, Scherneck S, Sobol H, Jacquemier J, Wagner T, Peto J, Stratton MR, McGuffog L, Easton DF; Breast Cancer Linkage Consortium. Lakhani SR, et al. Among authors: jacquemier j. Clin Cancer Res. 2005 Jul 15;11(14):5175-80. doi: 10.1158/1078-0432.CCR-04-2424. Clin Cancer Res. 2005. PMID: 16033833
Typical medullary breast carcinomas have a basal/myoepithelial phenotype.
Jacquemier J, Padovani L, Rabayrol L, Lakhani SR, Penault-Llorca F, Denoux Y, Fiche M, Figueiro P, Maisongrosse V, Ledoussal V, Martinez Penuela J, Udvarhely N, El Makdissi G, Ginestier C, Geneix J, Charafe-Jauffret E, Xerri L, Eisinger F, Birnbaum D, Sobol H; European Working Group for Breast Screening Pathology; Breast Cancer Linkage Consortium. Jacquemier J, et al. J Pathol. 2005 Nov;207(3):260-8. doi: 10.1002/path.1845. J Pathol. 2005. PMID: 16167361
Moesin expression is a marker of basal breast carcinomas.
Charafe-Jauffret E, Monville F, Bertucci F, Esterni B, Ginestier C, Finetti P, Cervera N, Geneix J, Hassanein M, Rabayrol L, Sobol H, Taranger-Charpin C, Xerri L, Viens P, Birnbaum D, Jacquemier J. Charafe-Jauffret E, et al. Among authors: jacquemier j. Int J Cancer. 2007 Oct 15;121(8):1779-85. doi: 10.1002/ijc.22923. Int J Cancer. 2007. PMID: 17594689
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists.
Badve S, Dabbs DJ, Schnitt SJ, Baehner FL, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR, Palacios J, Rakha EA, Richardson AL, Schmitt FC, Tan PH, Tse GM, Weigelt B, Ellis IO, Reis-Filho JS. Badve S, et al. Among authors: jacquemier j. Mod Pathol. 2011 Feb;24(2):157-67. doi: 10.1038/modpathol.2010.200. Epub 2010 Nov 12. Mod Pathol. 2011. PMID: 21076464 Free article. Review.
Breast cancer prognostic classification in the molecular era: the role of histological grade.
Rakha EA, Reis-Filho JS, Baehner F, Dabbs DJ, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR, Palacios J, Richardson AL, Schnitt SJ, Schmitt FC, Tan PH, Tse GM, Badve S, Ellis IO. Rakha EA, et al. Among authors: jacquemier j. Breast Cancer Res. 2010;12(4):207. doi: 10.1186/bcr2607. Epub 2010 Jul 30. Breast Cancer Res. 2010. PMID: 20804570 Free PMC article. Review.
Prediction of BRCA1 germ-line mutation status in patients with breast cancer using histoprognosis grade, MS110, Lys27H3, vimentin, and KI67.
Hassanein M, Huiart L, Bourdon V, Rabayrol L, Geneix J, Nogues C, Peyrat JP, Gesta P, Meynard P, Dreyfus H, Petrot D, Lidereau R, Noguchi T, Eisinger F, Extra JM, Viens P, Jacquemier J, Sobol H. Hassanein M, et al. Among authors: jacquemier j. Pathobiology. 2013;80(5):219-27. doi: 10.1159/000339432. Epub 2013 Apr 23. Pathobiology. 2013. PMID: 23614934 Free article.
Comparative multi-methodological measurement of ERBB2 status in breast cancer.
Ginestier C, Charafe-Jauffret E, Penault-Llorca F, Geneix J, Adélaïde J, Chaffanet M, Mozziconacci MJ, Hassoun J, Viens P, Birnbaum D, Jacquemier J. Ginestier C, et al. Among authors: jacquemier j. J Pathol. 2004 Mar;202(3):286-98. doi: 10.1002/path.1523. J Pathol. 2004. PMID: 14991893
A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene.
Huang HE, Chin SF, Ginestier C, Bardou VJ, Adélaïde J, Iyer NG, Garcia MJ, Pole JC, Callagy GM, Hewitt SM, Gullick WJ, Jacquemier J, Caldas C, Chaffanet M, Birnbaum D, Edwards PA. Huang HE, et al. Among authors: jacquemier j. Cancer Res. 2004 Oct 1;64(19):6840-4. doi: 10.1158/0008-5472.CAN-04-1762. Cancer Res. 2004. PMID: 15466169
331 results